Abstract
Acute dystonia is an abrupt event mainly related to toxicity of drugs such as antiemetics, antipsychotics, anti-acids, and, more rarely, tricyclic antidepressants. Use of amitriptyline in metachromatic leukodystrophy (MLD), a lysosomal storage disorder (LSD) due to arylsulfatase A deficiency, is suggested to control neurological pain and irritability. We describe a patient with MLD who experienced acute dystonia as a side effect of low dosage of amitriptyline. The distribution of psychotropic drugs, including antidepressants, depends upon lysosomal trapping which is inefficient in LSD. The defective lysosomal depot might raise cerebral levels of amitriptyline, thus enhancing its adverse effects.
Physicians caring for children with MLD treated with psychotropic drugs should be aware of such adverse events which are potentially related to lysosomal dysfunction. This experience raises a potential concern about the appropriate dose of amitriptyline in patients with MLD.
Competing interests: None declared
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arnone D, Hansen L, Kerr JS (2002) Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care. J Psychopharmacol 16:395–397
Baumann N, Turpin JC, Lefevre M, Colsch B (2002) Motor and psycho-cognitive clinical types in adult metachromatic leukodystrophy: genotype/phenotype relationships? J Physiol Paris 96:301–306
Baysal T, Oran B, Doğan M, Cimen D, Elmas S, Karaaslan S (2007) Beta-blocker treatment in an adolescent with amitriptyline intoxication. Anadolu Kardiyol Derg 7:324–325
Daniel WA (2003) Mechanisms of cellular distribution of psychotropic drugs significance for drug action and interactions. Prog Neuropsychopharmacol Biol Psychiatry 27:65–73
Daniel WA, Wójcikowski J, Pałucha A (2001) Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping. Br J Pharmacol 134:807–814
Doherty S, Cave G, Harvey M (2012) Paediatric amitriptyline overdose. Open J Pediatrics 2:170–174
Esen I, Demirpence S, Yis U, Kurul S (2008) Cetirizine-induced dystonic reaction in a 6-year-old boy. Pediatr Emerg Care 24:627–628
Finder E, Lin KM, Ananth J (1982) Dystonic reaction to amitriptyline. Am J Psychiatry 139:1220
Fournier-Charrière E (2010) Neuropathic pain in children. Arch Pediatr 17:665–666
Garcia G, Kaufman MB, Colucci RD (1994) Dystonic reaction associated with sumatriptan. Ann Pharmacother 28:1199
Gore M, Dukes E, Rowbotham D, Tai KS, Leslie DL (2006) Prevalence of contraindicated medical conditions and use of precluded medications in patients with painful neuropathic disorders prescribed amitriptyline. Pain Pract 6:265–272
Hauer JM, Wical BS, Charnas L (2007) Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment. Pediatrics 119:e519–e522
Kapur V, Barber KR, Peddireddy R (1999) Ranitidine-induced acute dystonia. Am J Emerg Med 17:258–260
Kim TS, Kim IO, Kim WS, Choi YS, Yeon KM, Hwang YS (1996) Involvement of the gallbladder in childhood metachromatic leukodystrophy: ultrasonographic findings. J Ultrasound Med 15:821–825
Lee HK (1988) Dystonic reactions to amitriptyline and doxepin. Am J Psychiatry 145:649
Lee K, Carson L, Kinnin E, Patterson V (1989) The Ashworth Scale: A Reliable and Reproducible Method of Measuring Spasticity. Neurorehabil Neural Repair 3:205–209
Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Therapeutics 30:239–245
Ornadel D, Barnes EA, Dick DJ (1999) Acute dystonia due to amitriptyline. J Neurol Neurosurg Psychiatry 55:414
Patel A, Mittal S, Manchanda S, Puliyel JM (2011) Ondansetron-induced dystonia, hypoglycemia, and seizures in a child. Ann Pharmacother 45:e7
Polizzi A, Incorpora G, Ruggieri M (2001) Dystonia as acute adverse reaction to cough suppressant in a 3-year-old girl. Eur J Paediatr Neurol 5:167–168
Shapiro BE, Hatters-Friedman S, Fernandes-Filho JA, Anthony K, Natowicz MR (2006) Late-onset Tay-Sachs disease: adverse effects of medications and implications for treatment. Neurology 67:875–877
Tchan MC, Sillence D (2009) Extrapyramidal symptoms and medication use in mucopolysaccharidosis type III. J Intellect Dev Disabil 34:275–279
The Evanosky Foundation (2008) Pain and symptoms management. http://www.evanoskyfoundation.org/MLD%20Care%20Plan%20031408.pdf
Van Harten PN, Hoek HW, Kahn RS (1999) Acute dystonia induced by drug treatment. BMJ 319:623–626
Vernon DD, Gleich MC (1997) Poisoning and drug overdose. Crit Care Clin 13:647–667
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Verena Peters
Rights and permissions
Copyright information
© 2012 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cappuccio, G., Brunetti-Pierri, N., Terrone, G., Romano, A., Andria, G., Del Giudice, E. (2012). Low-Dose Amitriptyline-Induced Acute Dystonia in a Patient with Metachromatic Leukodystrophy. In: Zschocke, J., Gibson, K.M., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports – Case and Research Reports, 2012/6. JIMD Reports, vol 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2012_188
Download citation
DOI: https://doi.org/10.1007/8904_2012_188
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-35517-2
Online ISBN: 978-3-642-35518-9
eBook Packages: MedicineMedicine (R0)